Letter: Predictors of Mortality After Endovascular Intervention in Patients With Peripheral Artery Disease

Abstract

Get full access to this article

View all access options for this article.

References

Murat

Aydın

Sener

, et al. Impact of the pre-procedural pan-immune inflammation value on long-term mortality in patients with peripheral artery disease following endovascular treatment: a comparative study. Angiology. Published online October 31, 2025. doi:10.1177/00033197251383344

Arya

Binney

Khakharia

, et al. High hemoglobin A_1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization. J Vasc Surg. 2018;67(1):217-228.e1.

Mlekusch

Exner

Sabeti

, et al. Serum creatinine predicts mortality in patients with peripheral artery disease: influence of diabetes and hypertension. Atherosclerosis. 2004;175(2):361-367.

Klein

van der Graaf

Seegers

Moll

Mali

WP.

Long-term cardiovascular morbidity, mortality, and reintervention after endovascular treatment in patients with iliac artery disease: the Dutch Iliac Stent Trial Study. Radiology. 2004;232(2):491-498.

Piepenburg

Maslarska

Kaier

Mühlen

CVZ

Westermann

Hehrlein

The impact of COVID-19 on mortality and clinical characteristics in hospitalized patients with peripheral artery disease in the year 2020 in Germany. Angiology. 2025;76(8):759-765.